U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07319039) titled 'Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure: an fMRI Feasibility Study' on May 26, 2025.
Brief Summary: Dyspnea that persists despite optimal pathophysiological treatment is defined as persistent dyspnea.
Currently all brain functional magnetic resonnance imaging (fMRI) studies conducted to evaluate breathlessness have done so using healthy volunteers or concentrated on acute breathlessness. Little is known about chronic breathlessness patterns and their modulation by different triggers. Furthermore, it is currently assumed in palliative care literature that patients suffering from different advanced and ...